Description

Cabozantinib is an antineoplastic medication used to treat several types of cancer. In its capsule form, it is effective for metastatic medullary thyroid cancer. The tablet form is used for advanced kidney cancer, either alone or in combination with nivolumab as a first-line treatment. Additionally, cabozantinib is indicated for previously treated hepatocellular carcinoma (liver cancer) and for metastatic differentiated thyroid cancer in patients who are unable to receive radioactive iodine and have not responded well to prior treatments. This medication works by interfering with the growth of cancer cells, leading to their eventual destruction by the body. Source: LOINC

Basic Part Properties

Part Name
Cabozantinib
Part Display Name
Cabozantinib
Part Type
Component (Describes the core component or analyte measured)
Created On
2024-08-22
Construct for LOINC Short Name
Cabozantinib

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP443354-8

Language Variants Get Info

TagLanguageTranslation
fr-FRFrench (France)Cabozantinib
it-ITItalian (Italy)Cabozantinib
pl-PLPolish (Poland)Kabozantynib
zh-CNChinese (China)卡博替尼
Synonyms: XL184